RT @NIH_NIAMS: #NIAMSResearch @stanfordmed: “New-onset non-infectious pulmonary manifestations among patients with systemic #lupus erythema…
Wooohooo @RheumEpi
#NIAMSResearch @stanfordmed: “New-onset non-infectious pulmonary manifestations among patients with systemic #lupus erythematosus in Sweden” https://t.co/zTmYUG7NDr. Open Access paper @biomedcentral Arthritis Research & Therapy. @cedarssinai @karolinsk
@RheumEpi And here's a lay summary of our findings... 👇🏻 https://t.co/RXOZ6vCflG
RT @RheumEpi: Our new paper - hot off the presses with @mrossidescy _ New-onset non-infectious #pulmonary manifestations among patients wit…
RT @georgepapadapol: Incidencia de Manifestaciones Pulmonares No infecciosas de LES (En Suecia) ✅Tasa de incidencia:14 casos x1000 personas…
Our new paper - hot off the presses with @mrossidescy _ New-onset non-infectious #pulmonary manifestations among patients with #systemic #lupus in Sweden https://t.co/pmKLb4mGYB
👀👀
RT @RheumNow: Study of 3209 incident lupus pts in Sweden shows lung dz to be 6 fold more common than controls (IR 14/1000 Pt Yrs), includin…
RT @RheumNow: Study of 3209 incident lupus pts in Sweden shows lung dz to be 6 fold more common than controls (IR 14/1000 Pt Yrs), includin…
RT @RheumNow: Study of 3209 incident lupus pts in Sweden shows lung dz to be 6 fold more common than controls (IR 14/1000 Pt Yrs), includin…
RT @RheumNow: Study of 3209 incident lupus pts in Sweden shows lung dz to be 6 fold more common than controls (IR 14/1000 Pt Yrs), includin…
Study of 3209 incident lupus pts in Sweden shows lung dz to be 6 fold more common than controls (IR 14/1000 Pt Yrs), including a 19 fold higher risk of interstitial lung disease. https://t.co/olLejMXv6j